Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
NCT Number: NCT03090386
This study is to evaluate which cognitive-linguistic symptoms are most commonly experienced following brain tumor treatment. Cognitive surveys will be administered after treatment of primary brain tumor cancer.
Looking for future studies?
Notify Me18 year–89 year
All sexes
Observational
Rochester, Minnesota, 55905, United States
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Complete the Cognitive Communication Survey, standardized cognitive and language assessments, and the Follow-up Cognitive Communication Survey after treatment
Time frame: 1 day at time of consent
Survey is completed at time of consent
Time frame: within 3 months of cognitive communication survey
Standardized testing will be completed
Time frame: within 6 months after completion of standardized testing
Survey will be completed
Mayo Clinic
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02153957
Behavior, Brain Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT02851706
Astrocytoma, Brain Cancer
Bethesda, Maryland, United States
View Trial DetailsNCT06368310
Brain Diseases, Brain Neoplasms
Salford, Greater Manchester, United Kingdom
View Trial DetailsNCT05776602
Brain Diseases, Brain Neoplasms
Stockholm, Stockholm County, Sweden
View Trial Details